DOC 2026: Science on the Brink

The DOC Magic returns.

It’s taken me a few days to recover from the crescendo that was DOC last week. Planning and executing a magical three-day gathering of 300+ brilliant scientists, investors, entrepreneurs, and policy leaders is both exhausting and exhilarating. It’s a bit like throwing a wedding, or a 72-hour long dinner party. The goal is to give every single guest a massive return on their most precious resource: Time.

Given DOC’s core focus on the science of longevity, time is the appropriate focal point. The room buzzed with extraordinary breakthroughs that are improving and expanding our healthspan — the period we spend engaged in a healthy, happy life. Consistent with DOC’s brand, we eschewed bullshit, focused on the evidence, and had a lot of fun along the way. DOC operates under Chatham House rule, which means I can’t directly quote most of our speakers, but there were plenty of insights to share — as well as some great photographs.

DOC CEO Dr. Neil Parikh

The first big moment — at least for me, personally — was when we handed the baton to Dr. Neil Parikh, who became the CEO of DOC earlier this year. Neil began the first morning with a call to action: Dubious claims based on poorly investigated science flood the longevity “market.” Thanks to market pressures and the rise of online influencers, the past decade has seen an erosion of consensus-based scientific guidelines. Those guidelines used to form a critical link between claims made in commercial markets and the core science behind them. Without them, “longevity” becomes a Wild West where marketing trumps truth. DOC’s mission — and the mission of everyone in the DOC community — is to become the trusted voice of truth amid a market driven by hype, hope, and extraordinary opportunity.

Asking questions is the point.

Over the next two days, the DOC community delivered on that mission. We debated the fate of the American healthcare system (the consensus opinion: We must build a new system outside of our current, broken one). We had a spirited argument about peptides — the poster child for a profit-driven, evidence-light sector of the longevity market. And we heard from dogged, perspicacious scientists determined to bring their work out of the lab and into all our lives.

Drs. Eddie Chang, Laura Esserman, and Leeanne Williams with DOC co-founder Dr. Jordan Shlain.

Our first session featured three such scientists – all of whom presented their original work on the DOC stage in years past. Dr. Leanne Williams recently discovered a new model for diagnosis and treatment of mental health conditions.  Her work in precision psychiatry is revolutionizing a field that, prior to her findings, was driven mostly by trial and error. Dr. Eddie Chang presented the latest findings in his breakthrough work on decoding how the brain creates and communicates language – work that is on the brink of unlocking a functional digital model of the brain itself. And Dr. Laura Esserman reported on her growing WISDOM study – which is dramatically improving the diagnosis and treatment of breast cancer.

We then heard updates from three leaders in core longevity science –Nir Barzilai, M.D., from the Institute for Aging Research at Albert Einstein College of Medicine, Deepak Srivastava, M.D., of the Gladstone Institutes, and Eric Verdin, M.D., of the Buck Institute for Research on Aging. Listening to these scientists, I was struck by both their optimism and their concerns: Thanks to technology, in particular AI, longevity medicine stands on the brink of extraordinary advances. But if we are to harness those breakthroughs, we have to continue to honor (and fund!) the core principles of scientific inquiry.

When those breakthroughs do make it to market, it’s likely you’ll find them in DOC’s Living Room Lab, which added a Skin Lab to the mix this year. Together more than 15 diagnostic and therapeutic companies presented their evidence-backed products and services. Harvard’s Dr. Shadi Kourosh, a DOC advisor, helped organize our lab and our skin-related programming – and delivered a rousing presentation on the critical role our skin plays in our healthspan. The skin remembers, Kourosh advised us. And it has much to teach us.

Dr. Shadi Kourosh, far right, talks to DOC Fellows after her presentation.

For the first time, DOC reserved a substantial portion of the program for more than a dozen deep-dive breakout sessions. Experts led conversations on topics ranging from the legal implications of AI on medical practices to how to pitch the government for research funds (pro tip: pitch the ideas you know traditional investors wouldn’t back).

A candid conversation with Orrick healthcare partner Jeremy Sherer.
The DOC House Band

After an afternoon of breakouts and visits to the Living Room and Skin Labs, we convened for dinner and networking, followed by what was perhaps my favorite DOC moment of the year: Live music with the “DOC House Band,” which featured several members of the DOC community and Faculty, including Dr. Len Zon, who helped develop pluripotent stem cells among countless other achievements, Dr. Ami Bhatt, the Chief Medical Officer of Whoop, and our own Dr. Jordan Shlain. A packed house of DOC faithful danced and sang along for hours. For me, playing drums behind a happy group of musicians and revelers is the most fun you can have with your clothes on.

Do we have to stop?!

The next day we were up early to engage with more mind-blowing science and AI.  Nicole Gaudelli, Ph.D., the inventor of the Adenine Base Editor, introduced us to Dr. Bill Peranteau, a fetal surgeon who is working on applying Gaudelli’s discoveries toward correcting genetic birth defects pre-natally. The logical end point of their work? An end to the expression of all genetic diseases. Truly mind blowing stuff.

We then heard from practicing doctors on the impact of AI on the delivery of care – including a epic story about how one patient went “founder mode” on his cancer, discovering scaleable approaches to combatting cancer along the way. Speaking of founders, we next heard from Divesh Makan, one of the most respected (and powerful) investors in Silicon Valley, on how AI is reshaping healthtech and business at large. We closed the formal program with  George D. Yancopoulos, M.D., Ph.D., founder and Chief Scientist of Regeneron. Yancopoulos brought all the threads of DOC together in that final conversation: he’s convinced that the data already exists to cure all disease. We just have to discover, structure, and apply our best technology to it. Using the science of genomics and multiomics, Yancopoulos is already deep into that work, and is on the brink of scaling that work to tens of millions of people around the globe.

I left DOC inspired and with a strong sense that we are on the brink of exponential improvements in medicine and proactive healthcare. But I also left with a bit of apprehension: the science and technology driving these breakthroughs are outpacing our society’s ability to understand them. When that happens, the door swings open to charlatans and profiteers. It’s up to all of us – doctors, truth seekers, investors, and business leaders – to make sure that in the end, science wins.

A toast to DOC’s 2026 class of DOC Fellows.
And a huge shout out to the mighty DOC team, pictured here are Editor Lauren Barack, EP Stacey Foreman, and Faculty Producer Julia Cashin. Not pictured but also mighty: Concierge Alison Valdes and Head of Partnerships Flora Lels Carpenter.

DOC is coming back again in 2027, with salons, dinners, editorial products, and of course our annual gathering. To stay connected, sign up for our newsletter here!

—

You can follow whatever I’m doing next by signing up for my site newsletter here. Thanks for reading.

Leave a Reply

Your email address will not be published. Required fields are marked *